297 related articles for article (PubMed ID: 38228976)
1. Gut Microbiome and Polycystic Ovary Syndrome: Interplay of Associated Microbial-Metabolite Pathways and Therapeutic Strategies.
Babu A; Devi Rajeswari V; Ganesh V; Das S; Dhanasekaran S; Usha Rani G; Ramanathan G
Reprod Sci; 2024 Jun; 31(6):1508-1520. PubMed ID: 38228976
[TBL] [Abstract][Full Text] [Related]
2. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
Yurtdaş G; Akdevelioğlu Y
J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus.
Duan L; An X; Zhang Y; Jin D; Zhao S; Zhou R; Duan Y; Zhang Y; Liu X; Lian F
Biomed Pharmacother; 2021 Oct; 142():112094. PubMed ID: 34449321
[TBL] [Abstract][Full Text] [Related]
4. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.
Liang Z; Di N; Li L; Yang D
J Endocrinol Invest; 2021 Aug; 44(8):1727-1737. PubMed ID: 33387350
[TBL] [Abstract][Full Text] [Related]
6. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
[TBL] [Abstract][Full Text] [Related]
7. Present and Future: Crosstalks Between Polycystic Ovary Syndrome and Gut Metabolites Relating to Gut Microbiota.
Zhang M; Hu R; Huang Y; Zhou F; Li F; Liu Z; Geng Y; Dong H; Ma W; Song K; Song Y
Front Endocrinol (Lausanne); 2022; 13():933110. PubMed ID: 35928893
[TBL] [Abstract][Full Text] [Related]
8. Effects of Sleeve Gastrectomy on Fecal Gut Microbiota and Short-Chain Fatty Acid Content in a Rat Model of Polycystic Ovary Syndrome.
Lin W; Wen L; Wen J; Xiang G
Front Endocrinol (Lausanne); 2021; 12():747888. PubMed ID: 34858330
[TBL] [Abstract][Full Text] [Related]
9. Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota.
He Y; Wang Q; Li X; Wang G; Zhao J; Zhang H; Chen W
Food Funct; 2020 Jun; 11(6):5192-5204. PubMed ID: 32441726
[TBL] [Abstract][Full Text] [Related]
10. Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice.
Zhang H; Zheng L; Li C; Jing J; Li Z; Sun S; Xue T; Zhang K; Xue M; Cao C; Ouyang L; Qian Z; Xu R; He Z; Ma R; Chen L; Yao B
J Ovarian Res; 2023 Jul; 16(1):138. PubMed ID: 37443082
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the therapeutic potential of moxibustion on polycystic ovary syndrome: a rat model study on gut microbiota and metabolite interaction.
Lin Y; Zeng H; Lin J; Peng Y; Que X; Wang L; Chen L; Bai N
Front Cell Infect Microbiol; 2024; 14():1328741. PubMed ID: 38665877
[TBL] [Abstract][Full Text] [Related]
12. The Human Gut Microbiome as a Potential Factor in Autism Spectrum Disorder.
Alharthi A; Alhazmi S; Alburae N; Bahieldin A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163286
[TBL] [Abstract][Full Text] [Related]
13. Intersection of Polycystic Ovary Syndrome and the Gut Microbiome.
Rizk MG; Thackray VG
J Endocr Soc; 2021 Feb; 5(2):bvaa177. PubMed ID: 33381671
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.
Zeng B; Lai Z; Sun L; Zhang Z; Yang J; Li Z; Lin J; Zhang Z
Res Microbiol; 2019; 170(1):43-52. PubMed ID: 30292647
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review.
Guo J; Shao J; Yang Y; Niu X; Liao J; Zhao Q; Wang D; Li S; Hu J
Reprod Sci; 2022 Jan; 29(1):69-83. PubMed ID: 33409871
[TBL] [Abstract][Full Text] [Related]
16. Application of Microbiome-Based Therapies in Chronic Respiratory Diseases.
Lee SH; Lee JH; Lee SW
J Microbiol; 2024 Mar; 62(3):201-216. PubMed ID: 38635003
[TBL] [Abstract][Full Text] [Related]
17. Polycystic Ovary Syndrome and Endometrial Cancer: A Scoping Review of the Literature on Gut Microbiota.
Prakash A; Nourianpour M; Senok A; Atiomo W
Cells; 2022 Sep; 11(19):. PubMed ID: 36231000
[TBL] [Abstract][Full Text] [Related]
18. Exploration of the pathogenesis of polycystic ovary syndrome based on gut microbiota: A review.
Guo H; Luo J; Lin H
Medicine (Baltimore); 2023 Dec; 102(50):e36075. PubMed ID: 38115365
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.
Liang Y; Cui L; Gao J; Zhu M; Zhang Y; Zhang HL
Mol Neurobiol; 2021 Aug; 58(8):3745-3758. PubMed ID: 33825149
[TBL] [Abstract][Full Text] [Related]
20. Exposure to a Healthy Gut Microbiome Protects Against Reproductive and Metabolic Dysregulation in a PCOS Mouse Model.
Torres PJ; Ho BS; Arroyo P; Sau L; Chen A; Kelley ST; Thackray VG
Endocrinology; 2019 May; 160(5):1193-1204. PubMed ID: 30924862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]